Jazz Pharmaceuticals (JAZZ) Shares Outstanding (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Shares Outstanding (Entity) of $62.7 million for Q1 2026, up 1.8% year-over-year from $61.6 million in Q1 2025, and up 2.19% quarter-over-quarter from $61.4 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Shares Outstanding (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $62.7 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1.8% year-over-year to $62.7 million; the TTM figure through Mar 2026 stood at $62.7 million (up 1.8% YoY), while the FY2025 annual figure was $61.4 million, up 1.27% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $62.7 million, up from $61.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $64.0 million in Q1 2023, with the low at $60.5 million in Q3 2024.
- The 5-year median for Shares Outstanding (Entity) is $62.3 million (2023), against an average of $62.2 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) rose 9.44% in 2022, then declined 3.97% in 2024.
- Jazz Pharmaceuticals' Shares Outstanding (Entity) stood at $63.2 million in 2022, then fell by 1.52% to $62.3 million in 2023, then fell by 2.61% to $60.6 million in 2024, then increased by 1.27% to $61.4 million in 2025, then grew by 2.19% to $62.7 million in 2026.
- Business Quant data shows JAZZ's Shares Outstanding (Entity) at $62.7 million in Q1 2026, $61.4 million in Q4 2025, and $60.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 63.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.20 Mn |
| Mar 31, 2026 | 61.90 Mn |
| Dec 31, 2025 | 60.98 Mn |
| Sep 30, 2025 | 60.70 Mn |
| Jun 30, 2025 | 61.19 Mn |
| Mar 31, 2025 | 61.00 Mn |
| Dec 31, 2024 | 61.84 Mn |
| Sep 30, 2024 | 61.41 Mn |
| Jun 30, 2024 | 62.88 Mn |
| Mar 31, 2024 | 62.54 Mn |
| Dec 31, 2023 | 63.29 Mn |
| Sep 30, 2023 | 63.11 Mn |
| Jun 30, 2023 | 63.99 Mn |
| Mar 31, 2023 | 63.49 Mn |
| Dec 31, 2022 | 62.54 Mn |
| Sep 30, 2022 | 62.79 Mn |
| Jun 30, 2022 | 62.44 Mn |
| Mar 31, 2022 | 61.87 Mn |
| Dec 31, 2021 | 59.69 Mn |
| Sep 30, 2021 | 61.28 Mn |